The selling does not inspire a lot of faith but on the other hand the buying is keeping us level

Unless something really bad has transpired in the meantime, let's not forget that they rewarded themselves quite nicely a few weeks ago in the - just going by memory here - 80 cent range.

Also, Zenith is overdue for an update as well. June was officially mentioned from what I can remember reading.

We will see if Pfizer commits - that recently announced program sounds like it could have been handcrafted for a Resverlogix or Zenith, where they are still possibly miles apart on a buyout number but want to show their commitment.

Last but not least, the ORI fund. Seems like a nice price to convert at.